List of bibliographic references
Number of relevant bibliographic references: 19.
Ident. | Authors (with country if any) | Title |
---|
000095 (2020) |
Chi Zhang [République populaire de Chine] ; Zhao Wu [République populaire de Chine] ; Jia-Wen Li [République populaire de Chine] ; Hong Zhao [République populaire de Chine] ; Gui-Qiang Wang [République populaire de Chine] | The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist Tocilizumab may be the key to reduce the mortality |
000106 (2020) |
Akram Aminjafari [Iran] ; Sorayya Ghasemi [Iran] | The Possible of Immunotherapy for COVID-19: a Systematic Review |
000211 (2020) |
Keith W. Kelley [États-Unis] ; Yu-Ping Peng [République populaire de Chine] ; Quentin Liu [République populaire de Chine] ; Hui-Chih Chang [Taïwan] ; Sarah J. Spencer [Australie] ; Mark R. Hutchinson ; Atsuyoshi Shimada [Japon] | Psychoneuroimmunology goes East: Development of the PNIRSChina affiliate and its expansion into PNIRSAsia-Pacific |
000237 (2020) |
Zaid H. Temrikar [États-Unis] ; Satyendra Suryawanshi [États-Unis] ; Bernd Meibohm [États-Unis] | Pharmacokinetics and Clinical Pharmacology of Monoclonal Antibodies in Pediatric Patients |
000243 (2020) |
Yong-Jian Geng [États-Unis] ; Zhi-Yao Wei [République populaire de Chine] ; Hai-Yan Qian [République populaire de Chine] ; Ji Huang [République populaire de Chine] ; Robert Lodato [États-Unis] ; Richard J. Castriotta [États-Unis] | Pathophysiological Characteristics and Therapeutic Approaches for Pulmonary Injury and Cardiovascular Complications of Coronavirus Disease 2019 |
000284 (2020) |
Prativa Sahoo [États-Unis] ; Xin Yang [États-Unis] ; Daniel Abler [États-Unis] ; Davide Maestrini [États-Unis] ; Vikram Adhikarla [États-Unis] ; David Frankhouser [États-Unis] ; Heyrim Cho [États-Unis] ; Vanessa Machuca [États-Unis] ; Dongrui Wang [États-Unis] ; Michael Barish [États-Unis] ; Margarita Gutova [États-Unis] ; Sergio Branciamore [États-Unis] ; Christine E. Brown [États-Unis] ; Russell C. Rockne [États-Unis] | Mathematical deconvolution of CAR T-cell proliferation and exhaustion from real-time killing assay data |
000323 (2020) |
Mingxuan Xie [République populaire de Chine] ; Qiong Chen [République populaire de Chine] | Insight into 2019 novel coronavirus — an updated intrim review and lessons from SARS-CoV and MERS-CoV |
000325 (2020) |
Zachary A. Yetmar [États-Unis] ; Meltiady Issa [États-Unis] ; Sadia Munawar [États-Unis] ; M. Caroline Burton [États-Unis] ; Vincent Pureza [États-Unis] ; M. Rizwan Sohail [États-Unis] ; Tahir Mehmood [États-Unis] | Inpatient Care of Patients with COVID-19: A Guide for Hospitalists |
000371 (2020) |
Kishan P. Patel [États-Unis] ; Puja A. Patel [États-Unis] ; Rama R. Vunnam [États-Unis] ; Alexander T. Hewlett [États-Unis] ; Rohit Jain [États-Unis] ; Ran Jing [États-Unis] ; Srinivas R. Vunnam [États-Unis] | Gastrointestinal, Hepatobiliary, and Pancreatic Manifestations of COVID-19 |
000447 (2020) |
Ming Zhao [République populaire de Chine] | Cytokine storm and immunomodulatory therapy in COVID-19: role of chloroquine and anti-IL-6 monoclonal antibodies |
000452 (2020) |
Jiancheng Zhang [Japon, République populaire de Chine] ; Bing Xie [République populaire de Chine] ; Kenji Hashimoto [Japon] | Current status of potential therapeutic candidates for the COVID-19 crisis |
000465 (2020) |
Lulu Ma ; Kaicheng Song ; Yuguang Huang | Coronavirus disease 2019 (COVID-19) and cardiovascular complications |
000467 (2020) |
| Coronavirus Infection Among Children and Adolescents |
000490 (2020) |
Ashish Yashwantrao Pawar | Combating Devastating COVID -19 by Drug Repurposing |
000545 (2020) |
Giovanni Novi [Italie] ; Malgorzata Mikulska [Italie] ; Federica Briano [Italie] ; Federica Toscanini [Italie] ; Francesco Tazza [Italie] ; Antonio Uccelli [Italie] ; Matilde Inglese [Italie] | COVID-19 in a MS patient treated with ocrelizumab: does immunosuppression have a protective role? |
000555 (2020) |
Akhtar Hussain [Norvège, Brésil, Belgique, Inde, Bangladesh] ; Bishwajit Bhowmik [Bangladesh, Norvège] ; Nayla Cristina Do Vale Moreira [Brésil, Norvège] | COVID-19 and Diabetes: Knowledge in Progress |
000564 (2020) |
Fabrizio Cantini [Italie] ; Laura Niccoli [Italie] ; Daniela Matarrese [Italie] ; Emanuele Nicastri [Italie] ; Paolo Stobbione [Italie] ; Delia Goletti [Italie] | Baricitinib therapy in COVID-19: A pilot study on safety and clinical impact |
000610 (2020) |
Antoney J. Ferrey [États-Unis] ; Grace Choi [États-Unis] ; Ramy M. Hanna [États-Unis] ; Yongen Chang [États-Unis] ; Ekamol Tantisattamo [États-Unis] ; Kaushik Ivaturi [États-Unis] ; Elisa Park [États-Unis] ; Lawrence Nguyen [États-Unis] ; Brian Wang [États-Unis] ; Sam Tonthat [États-Unis] ; Connie M. Rhee [États-Unis] ; Uttam Reddy [États-Unis] ; Wei Ling Lau [États-Unis] ; Susan S. Huang [États-Unis] ; Shruti Gohil [États-Unis] ; Alpesh N. Amin [États-Unis] ; Lanny Hsieh [États-Unis] ; Timmy T. Cheng [États-Unis] ; Richard A. Lee [États-Unis] ; Kamyar Kalantar-Zadeh [États-Unis] | A Case of Novel Coronavirus Disease 19 in a Chronic Hemodialysis Patient Presenting with Gastroenteritis and Developing Severe Pulmonary Disease |
000620 (2019) |
Surinder M. Soond [Russie] ; Maria V. Kozhevnikova ; Paul A. Townsend ; Andrey A. Zamyatnin [Russie] | Cysteine Cathepsin Protease Inhibition: An update on its Diagnostic, Prognostic and Therapeutic Potential in Cancer |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/2020/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i -k "highlights"
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i \
-Sk "highlights" \
| HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= TocilizumabV1
|flux= 2020
|étape= Analysis
|type= indexItem
|index= AbsEn.i
|clé= highlights
}}
| This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021 | |